The phosphoinositide-3-kinase (PI3K)-delta and gamma inhibitor, IPI-145 (Duvelisib), overcomes signals from the PI3K/AKT/S6 pathway and promotes apoptosis in CLL
Balakrishnan, K, Peluso, M, Fu, M, Rosin, N Y, Burger, J A, Wierda, W G, Keating, M J, Faia, K, O'Brien, S, Kutok, J L, Gandhi, V
Published in Leukemia (01.09.2015)
Published in Leukemia (01.09.2015)
Get full text
Journal Article
A prognostic score for patients with lower risk myelodysplastic syndrome
Garcia-Manero, G, Shan, J, Faderl, S, Cortes, J, Ravandi, F, Borthakur, G, Wierda, W G, Pierce, S, Estey, E, Liu, J, Huang, X, Kantarjian, H
Published in Leukemia (01.03.2008)
Published in Leukemia (01.03.2008)
Get full text
Journal Article
Selective, novel spleen tyrosine kinase (Syk) inhibitors suppress chronic lymphocytic leukemia B-cell activation and migration
Hoellenriegel, J, Coffey, G P, Sinha, U, Pandey, A, Sivina, M, Ferrajoli, A, Ravandi, F, Wierda, W G, O'Brien, S, Keating, M J, Burger, J A
Published in Leukemia (01.07.2012)
Published in Leukemia (01.07.2012)
Get full text
Journal Article
A phase I study of immune gene therapy for patients with CLL using a membrane-stable, humanized CD154
Wierda, W G, Castro, J E, Aguillon, R, Sampath, D, Jalayer, A, McMannis, J, Prussak, C E, Keating, M, Kipps, T J
Published in Leukemia (01.11.2010)
Published in Leukemia (01.11.2010)
Get full text
Journal Article
Increased expression of CD152 (CTLA-4) by normal T lymphocytes in untreated patients with B-cell chronic lymphocytic leukemia
MOTTA, M, RASSENTI, L, SHELVIN, B. J, LERNER, S, KIPPS, T. J, KEATING, M. J, WIERDA, W. G
Published in Leukemia (01.10.2005)
Published in Leukemia (01.10.2005)
Get full text
Journal Article
HLA homozygosity and haplotype bias among patients with chronic lymphocytic leukemia: implications for disease control by physiological immune surveillance
Shah, N, Decker, W K, Lapushin, R, Xing, D, Robinson, S N, Yang, H, Parmar, S, Tung, S S, O'Brien, S, Fernandez-Viña, M, Shpall, E J, Wierda, W G
Published in Leukemia (01.06.2011)
Published in Leukemia (01.06.2011)
Get full text
Journal Article
Increased mitochondrial biogenesis in primary leukemia cells: the role of endogenous nitric oxide and impact on sensitivity to fludarabine
CAREW, J. S, NAWROCKI, S. T, XU, R. H, DUNNER, K. JR, MCCONKEY, D. J, WIERDA, W. G, KEATING, M. J, HUANG, P
Published in Leukemia (01.12.2004)
Published in Leukemia (01.12.2004)
Get full text
Journal Article
A complementary role of multiparameter flow cytometry and high-throughput sequencing for minimal residual disease detection in chronic lymphocytic leukemia: an European Research Initiative on CLL study
Rawstron, A C, Fazi, C, Agathangelidis, A, Villamor, N, Letestu, R, Nomdedeu, J, Palacio, C, Stehlikova, O, Kreuzer, K-A, Liptrot, S, O'Brien, D, de Tute, R M, Marinov, I, Hauwel, M, Spacek, M, Dobber, J, Kater, A P, Gambell, P, Soosapilla, A, Lozanski, G, Brachtl, G, Lin, K, Boysen, J, Hanson, C, Jorgensen, J L, Stetler-Stevenson, M, Yuan, C, Broome, H E, Rassenti, L, Craig, F, Delgado, J, Moreno, C, Bosch, F, Egle, A, Doubek, M, Pospisilova, S, Mulligan, S, Westerman, D, Sanders, C M, Emerson, R, Robins, H S, Kirsch, I, Shanafelt, T, Pettitt, A, Kipps, T J, Wierda, W G, Cymbalista, F, Hallek, M, Hillmen, P, Montserrat, E, Ghia, P
Published in Leukemia (01.04.2016)
Published in Leukemia (01.04.2016)
Get full text
Journal Article
Duvelisib treatment is associated with altered expression of apoptotic regulators that helps in sensitization of chronic lymphocytic leukemia cells to venetoclax (ABT-199)
Patel, V M, Balakrishnan, K, Douglas, M, Tibbitts, T, Xu, E Y, Kutok, J L, Ayers, M, Sarkar, A, Guerrieri, R, Wierda, W G, O'Brien, S, Jain, N, Stern, H M, Gandhi, V
Published in Leukemia (01.09.2017)
Published in Leukemia (01.09.2017)
Get full text
Journal Article
Long-term outcomes of Sleeping Beauty–generated CD19-specific CAR T-cell therapy for relapsed-refractory B-cell lymphomas
Srour, S.A., Singh, H., McCarty, J., de Groot, E., Huls, H., Rondon, G., Qazilbash, M., Ciurea, S., Bardelli, G., Buck, J., Alousi, A., Nieto, Y., Rezvani, K., Marin, D., Popat, U., Hosing, C., Shpall, E.J., Wierda, W.G., Kantarjian, H., Champlin, R.E., Cooper, L.J., Kebriaei, P.
Published in Blood (12.03.2020)
Published in Blood (12.03.2020)
Get full text
Journal Article
Incidence and prognostic impact of other cancers in a population of long-term survivors of chronic lymphocytic leukemia
Falchi, L., Vitale, C., Keating, M.J., Lerner, S., Wang, X., Elhor Gbito, K.Y., Strom, S., Wierda, W.G., Ferrajoli, A.
Published in Annals of oncology (01.06.2016)
Published in Annals of oncology (01.06.2016)
Get full text
Journal Article
Characteristics, outcomes, prognostic factors and treatment of patients with T-cell prolymphocytic leukemia (T-PLL)
Jain, P., Aoki, E., Keating, M., Wierda, W.G., O’Brien, S., Gonzalez, G.N., Ferrajoli, A., Jain, N., Thompson, P.A., Jabbour, E., Kanagal-Shamanna, R., Pierce, S., Alousi, A., Hosing, C., Khouri, I., Estrov, Z., Cortes, J., Kantarjian, H., Ravandi, F., Kadia, T.M.
Published in Annals of oncology (01.07.2017)
Published in Annals of oncology (01.07.2017)
Get full text
Journal Article
Pharmacodynamics and proteomic analysis of acalabrutinib therapy: similarity of on-target effects to ibrutinib and rationale for combination therapy
Patel, V K, Lamothe, B, Ayres, M L, Gay, J, Cheung, J P, Balakrishnan, K, Ivan, C, Morse, J, Nelson, M, Keating, M J, Wierda, W G, Marszalek, J R, Gandhi, V
Published in Leukemia (01.04.2018)
Published in Leukemia (01.04.2018)
Get full text
Journal Article
Failure is not fatal: long-term remission in refractory acute myeloid leukemia (AML) after graft failure of cord blood stem cells
Burger, J A, Velev, N S, Jabbour, E J, Wierda, W G, Ravandi, F, Cortes, J E, Kantarjian, H, Nieto, Y L, Shpall, E J, Jorgensen, J L
Published in Leukemia (01.03.2010)
Published in Leukemia (01.03.2010)
Get full text
Journal Article
FIXED‐DURATION IBRUTINIB + VENETOCLAX IN CHRONIC LYMPHOCYTIC LEUKEMIA (CLL)/SMALL LYMPHOCYTIC LYMPHOMA (SLL): 4‐Y FOLLOW‐UP FROM THE FD COHORT OF THE PHASE 2 CAPTIVATE STUDY
Ghia, P., Allan, J. N., Siddiqi, T., Wierda, W. G., Tam, C. S., Moreno, C., Tedeschi, A., Szafer‐Glusman, E., Zhou, C., Abbazio, C., Dean, J. P., Szoke, A., Barr, P. M.
Published in Hematological oncology (01.06.2023)
Published in Hematological oncology (01.06.2023)
Get full text
Journal Article
Zilovertamab vedotin (MK‐2140) in relapsed or refractory (R/R) non‐Hodgkin lymphoma (NHL): 14‐month follow‐up of the phase 1 waveLINE‐001 study
Wang, M. L., Mei, M., Barr, P. M., Barrientos, J. C., Vos, S., Furman, R. R., Patel, K., Wierda, W. G., Choi, M. Y., Kallam, A., Wang, S., Ogbu, U. C., Marinello, P., Spurgeon, S. E.
Published in Hematological oncology (01.06.2023)
Published in Hematological oncology (01.06.2023)
Get full text
Journal Article
Leukemia-cell proliferation and disease progression in patients with early stage chronic lymphocytic leukemia
Murphy, E J, Neuberg, D S, Rassenti, L Z, Hayes, G, Redd, R, Emson, C, Li, K, Brown, J R, Wierda, W G, Turner, S, Greaves, A W, Zent, C S, Byrd, J C, McConnel, C, Barrientos, J, Kay, N, Hellerstein, M K, Chiorazzi, N, Kipps, T J, Rai, K R
Published in Leukemia (01.06.2017)
Published in Leukemia (01.06.2017)
Get full text
Journal Article
GENOMIC EVOLUTION AND RESISTANCE TO PIRTOBRUTINIB IN COVALENT BTK‐INHIBITOR PRE‐TREATED CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS: RESULTS FROM THE PHASE I/II BRUIN STUDY
Patel, K., Brown, J. R., Desikan, S. P., Nguyen, B., Won, H., Tantawy, S. I., McNeely, S. C., Marella, N., Ebata, K., Woyach, J. A., Tam, C. S., Eyre, T. A., Cheah, C. Y., Shah, N. N., Ghia, P., Jurczak, W., Balbas, M., Nair, B., Abada, P., Wang, C., Wang, D., Mato, A. R., Gandhi, V., Wierda, W. G.
Published in Hematological oncology (01.06.2023)
Published in Hematological oncology (01.06.2023)
Get full text
Journal Article